$1.25m Raised to Support Next Phase of Growth

Summary by 6ix AI

Xenitra Limited has announced a successful capital raise of funds to support its growth initiatives. The company will issue shares and options to institutional and sophisticated investors as part of this placement. The raised funds will be used for expanding OTC medicines, scaling the OPAL RWA token ecosystem, and general working capital. Novus Capital Limited acted as the lead manager for this placement and will receive a fee along with shares and options.

Written by 6ix AI from the company’s filing. How 6ix writes summaries